Thresholds in genotoxicity responses

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 464, Issue 1, 2000, Pages 123-128

  Henderson, Leigh ^a   Albertini, Silvio ^b   Aardema, Marilyn ^c  

^a UNILEVER RESEARCH   (United Kingdom)

^b F HOFFMANN LA ROCHE LTD   (Switzerland)

^c PROCTER AND GAMBLE COMPANY   (United States)

Author keywords

Aneuploidy; Homeostatic overload; In vitro artefacts; Risk assessment of genotoxins; Threshold mechanisms in genotoxicity

Indexed keywords

CELL PROLIFERATION; CHROMOSOME ABERRATION; CONFERENCE PAPER; CYTOTOXICITY; DNA SYNTHESIS INHIBITION; DOSE RESPONSE; DRUG SCREENING; ENZYME INHIBITION; GENOTOXICITY; IN VITRO STUDY; INTERMETHOD COMPARISON; MAXIMUM ALLOWABLE CONCENTRATION; MICRONUCLEUS TEST; PRIORITY JOURNAL; RISK ASSESSMENT;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; EUROPE; HUMANS; LABORATORIES; MUTAGENICITY TESTS; MUTAGENS; QUESTIONNAIRES; RISK ASSESSMENT; UNITED STATES;

EID: 0033977140     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1383-5718(99)00173-4     Document Type: Conference Paper

References (25)

1. Kirkland D. Chromosome aberration testing in genetic toxicology - past, present and future. Mutat. Res. 404:1998;173-185.
2. Galloway S.M., Miller J.E., Armstrong M.J., Bean C.L., Skopek T.R., Nichols W.W. DNA synthesis inhibition as an indirect mechanism of chromosome aberrations: comparison of DNA-reactive and non-DNA-reactive clastogens. Mutat. Res. 400:1998;169-186.
3. Albertini S., Chételat A., Miller B., Muster W., Pujadas E., Strobel R., Gocke E. Genotoxicity of gyrase- and mammalian topoisomerase II-inhibitors in prokaryotic an eukaryotic test systems. Mutagenesis. 10:1995;343-351.
4. Haynes P., Lambert T.R., de Mitchell I.G. Comparative in vivo genotoxicty of antiviral nucleoside analogues; penciclovir, acyclovir, ganciclovir and the xanthine analogue, caffeine, in the mouse bone marrow micronucleus assay. Mutat. Res. 369:1996;65-74.
5. Kunz B.A., Kohalmi S.E., Kunkel T.A., Mathews C.K., McIntosh E.M., Reidy J.A. Deoxyribonucleoside triphosphate levels: a critical factor in the maintenance of genetic stability. Mutat. Res. 318:1994;1-64.
6. Favor J., Neuhauser-Klaus A., Ehling U.H., Wulff A., van Zeeland A.A. The effect of the interval between dose applications on the observed specific-locus mutation rate in the mouse following fractionated treatments of spermatogonia with ethylnitrosourea. Mutat. Res. 374:1997;193-199.
7. Favor J., Sund M., Neuhauser-Klaus A., Ehling E.U. A dose-response analysis of ethylnitrosourea-induced recessive specific-locus mutations in treated spermatogonia of the mouse. Mutat. Res. 231:1990;47-54.
8. Kim S.B., Kim I.S., Yeum D.M., Park Y.H. Mutagenicity of Maillard reaction products from D-glucose amino acid mixtures and possible roles of active oxygens in the mutagenicity. Mutat. Res. 254:1991;65-69.
9. Anderson D., Yu T.W., Phillips B.J., Schmezer P. The effect of various antioxidants and other modifying agents on oxygen-radical-generated DNA-damage in human lymphocytes in the Comet assay. Mutat. Res. 307:1994;261-271.
10. Panandiker A., Maru C.B., Rao K.V.K. Dose-response effects of malachite green on free-radical formation, lipid peroxidation and DNA damage in syrian hamster embryo cells and their modulation by antioxidants. Carcinogenesis. 15:1994;2445-2448.
11. Chételat A., Albertini S., Gocke E. The photomutagenicity of fluoroquinolones in tests for gene mutation, chromosomal aberration, gene conversion and DNA breakage (Comet assay). Mutagenesis. 11:1996;497-504.
12. Bergman K., Müller L., Weberg Teigen S. The genotoxicity and carcinogenicty of paracetamol: a regulatory (re)view. Mutat. Res. 349:1996;263-288.
13. Galloway S.M., Deasy D.A., Bean C.L., Kraynak A.R., Armstrong M.J., Bradley M.O. Effects of high osmotic strength on chromosome aberrations, sister-chromatid exchanges and DNA strand breaks, and the relation to toxicity. Mutat. Res. 189:1987;15-26.
14. Cifone M.A., Myhr B., Eiche A., Bolcsfoldi G. Effect of pH shifts on the mutant frequency at the thymidine kinase locus in mouse lymphoma L5178Y TK±cells. Mutat. Res. 189:1987;39-46.
15. Kirkland D. Chromosomal aberration testing in vitro: problems with protocol design and interpretation of results. Mutagenesis. 7:1992;95-106.
16. Hilliard C.A., Armstrong M.J., Bradt C.I., Hill R.B., Greenwood S.K., Galloway S.M. Chromosome aberrations in vitro related to cytotoxicity of nonmutagenic chemicals and metabolic poisons. Environ. Mol. Mutagen. 31:1998;316-326.
17. Yajima N., Kurata Y., Sawai T., Takeshita Y. Induction of micronucleated erthrocytes by recombinant-human-erythropoietin. Mutagenesis. 8:1993;221-229.
18. Hirai O., Miyame Y., Fujino Y., Izumi H., Miyamoto A., Noguchi H. Prior bleeding enhances the sensitivity of the in vivo micronucleus test. Mutat. Res. 264:1991;109-114.
19. Roberts R.A. Transgenic rodent mutation/cancer bioassays: cell cycle control, cell proliferation and apoptosis as modifiers of outcome. Mutat. Res. 398:1998;189-195.
20. Ashby J., Tinwell H., Burnett K., LeFevre P.A. Results for the Big Blue transgenic assay using two genotoxins and a peroxisome proliferator. Environ. Mol. Mutagen. 21(S22):1993;4.
21. Mirsalis J.C., Hamer J.D., O'Louglin K.G., Winegar R.A., Short J.M. Effects of nongenotoxic carcinogens on hepatic mutation in lacI transgenic mice. Environ. Mol. Mutagen. 21(S22):1993;48.
22. Mirsalis J.C., Monforte J.A., Winegar R.A. Transgenic animal models for measuring mutations in vivo. Crit. Rev. Toxicol. 24:1994;255-280.
23. Gunz D., Shephard S.E., Lutz W.K. Can nongenotoxic carcinogens be detected with the lacI transgenic mouse mutation assay? Environ. Mol. Mutagen. 21:1993;209-211.
24. Shephard S.E., Gunz D., Lutz W.K. Can "nongenotoxic" carcinogens be detected with the lacI transgenic mouse mutation assay? Environ. Mol. Mutagen. 21(S22):1993;64.
25. Binder R.L., Thompson E.D., Johnson G.R., Reer P.J., Myhr B.C., LeBoeuf R.A. Irritation may be mutagenic in the skin of MutaMouse. Environ. Mol. Mutagen. 19(S20):1992;6.